iso3c,country,year,vaccine,vaccine_code,vaccine_desc,value
ALB,Albania,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,15
ALB,Albania,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,15
AND,Andorra,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,49
AND,Andorra,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
AND,Andorra,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
AND,Andorra,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
AND,Andorra,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
AND,Andorra,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,49
AND,Andorra,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
AND,Andorra,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
AND,Andorra,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
AND,Andorra,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
AND,Andorra,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,49
AND,Andorra,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64
AND,Andorra,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,49
AND,Andorra,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
ARE,United Arab Emirates,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33
ARE,United Arab Emirates,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34
ARE,United Arab Emirates,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
ARE,United Arab Emirates,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,43
ARE,United Arab Emirates,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,41
ARE,United Arab Emirates,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
ARE,United Arab Emirates,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
ARE,United Arab Emirates,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
ARE,United Arab Emirates,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
ARE,United Arab Emirates,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
ARE,United Arab Emirates,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,54
ARE,United Arab Emirates,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46
ARE,United Arab Emirates,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,36
ARE,United Arab Emirates,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,36
ARG,Argentina,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
ARG,Argentina,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
ARG,Argentina,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
ARG,Argentina,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
ARG,Argentina,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
ARG,Argentina,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
ARG,Argentina,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
ARG,Argentina,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
ARG,Argentina,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
ARG,Argentina,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
ARG,Argentina,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
ARG,Argentina,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
ARG,Argentina,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
ARG,Argentina,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
ARG,Argentina,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,60
ARG,Argentina,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,57
ARG,Argentina,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
ARG,Argentina,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
ARG,Argentina,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
ARG,Argentina,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
ARG,Argentina,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,60
ARG,Argentina,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46
ARG,Argentina,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
ARG,Argentina,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
ARG,Argentina,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63
ARG,Argentina,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
ARG,Argentina,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
ARG,Argentina,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
ARG,Argentina,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
ARG,Argentina,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
ARG,Argentina,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
ARG,Argentina,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,93
ARG,Argentina,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
ARG,Argentina,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
ARG,Argentina,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
ARG,Argentina,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
ARG,Argentina,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
ARG,Argentina,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
ARG,Argentina,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
ARM,Armenia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
ARM,Armenia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19
ARM,Armenia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12
ARM,Armenia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11
ARM,Armenia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,43
ARM,Armenia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
ARM,Armenia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
ARM,Armenia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,10
ARM,Armenia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9
ARM,Armenia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,15
ARM,Armenia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8
ARM,Armenia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,19
ARM,Armenia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12
ARM,Armenia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2
ARM,Armenia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8
ARM,Armenia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,10
ATG,Antigua and Barbuda,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11
ATG,Antigua and Barbuda,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11
ATG,Antigua and Barbuda,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
ATG,Antigua and Barbuda,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
AUS,Australia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
AUS,Australia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
AUS,Australia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
AUS,Australia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
AUS,Australia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
AUS,Australia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
AUS,Australia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
AUS,Australia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
AUS,Australia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
AUS,Australia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
AUS,Australia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
AUS,Australia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
AUS,Australia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
AUS,Australia,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67
AUS,Australia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
AUS,Australia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65
AUS,Australia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
AUS,Australia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
AUS,Australia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
AUS,Australia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
AUS,Australia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
AUS,Australia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,75
AUS,Australia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
AUS,Australia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67
AUS,Australia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
AUS,Australia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
AUS,Australia,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
AUS,Australia,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
AUS,Australia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
AUS,Australia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
AUS,Australia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
AUS,Australia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
AUS,Australia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
AUS,Australia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
AUS,Australia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
AUS,Australia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
AUS,Australia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
AUS,Australia,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
AUS,Australia,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
AUS,Australia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
AUS,Australia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,79
AUS,Australia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
AUS,Australia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
AUS,Australia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,77
AUS,Australia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
AUS,Australia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
AUS,Australia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
AUS,Australia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
AUT,Austria,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,5
AUT,Austria,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9
AUT,Austria,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,17
AUT,Austria,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,26
AUT,Austria,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35
AUT,Austria,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
AUT,Austria,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
AUT,Austria,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
AUT,Austria,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5
AUT,Austria,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9
AUT,Austria,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
AUT,Austria,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,26
AUT,Austria,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35
AUT,Austria,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
AUT,Austria,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,53
AUT,Austria,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,53
AUT,Austria,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,5
AUT,Austria,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,9
AUT,Austria,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,17
AUT,Austria,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,26
AUT,Austria,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,35
AUT,Austria,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,45
AUT,Austria,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
AUT,Austria,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
AUT,Austria,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,5
AUT,Austria,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,9
AUT,Austria,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,17
AUT,Austria,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,26
AUT,Austria,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,35
AUT,Austria,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,45
AUT,Austria,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,53
AUT,Austria,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,53
BEL,Belgium,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
BEL,Belgium,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
BEL,Belgium,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
BEL,Belgium,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,69
BEL,Belgium,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
BEL,Belgium,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
BEL,Belgium,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
BEL,Belgium,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
BEL,Belgium,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
BEL,Belgium,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
BEL,Belgium,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
BEL,Belgium,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
BEL,Belgium,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
BEL,Belgium,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
BEL,Belgium,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
BEL,Belgium,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67
BEL,Belgium,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
BEL,Belgium,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,69
BEL,Belgium,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,69
BEL,Belgium,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,70
BEL,Belgium,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,70
BEL,Belgium,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,69
BEL,Belgium,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63
BEL,Belgium,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,65
BEL,Belgium,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
BEL,Belgium,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,69
BEL,Belgium,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
BEL,Belgium,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73
BEL,Belgium,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
BEL,Belgium,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,76
BEL,Belgium,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
BEL,Belgium,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
BEL,Belgium,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,61
BEL,Belgium,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
BEL,Belgium,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
BEL,Belgium,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
BEL,Belgium,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
BEL,Belgium,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
BEL,Belgium,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
BEL,Belgium,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
BEL,Belgium,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,70
BEL,Belgium,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,70
BFA,Burkina Faso,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
BFA,Burkina Faso,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,16
BGR,Bulgaria,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23
BGR,Bulgaria,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,15
BGR,Bulgaria,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7
BGR,Bulgaria,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,5
BGR,Bulgaria,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,5
BGR,Bulgaria,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8
BGR,Bulgaria,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7
BGR,Bulgaria,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4
BGR,Bulgaria,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2
BGR,Bulgaria,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1
BGR,Bulgaria,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20
BGR,Bulgaria,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
BGR,Bulgaria,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
BGR,Bulgaria,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3
BGR,Bulgaria,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
BGR,Bulgaria,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6
BGR,Bulgaria,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
BGR,Bulgaria,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3
BGR,Bulgaria,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1
BGR,Bulgaria,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1
BGR,Bulgaria,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,23
BGR,Bulgaria,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,18
BGR,Bulgaria,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12
BGR,Bulgaria,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,9
BGR,Bulgaria,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12
BGR,Bulgaria,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,14
BGR,Bulgaria,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,11
BGR,Bulgaria,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,21
BGR,Bulgaria,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,15
BGR,Bulgaria,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8
BGR,Bulgaria,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7
BGR,Bulgaria,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,9
BGR,Bulgaria,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,9
BGR,Bulgaria,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,9
BHS,Bahamas,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
BHS,Bahamas,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,41
BHS,Bahamas,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28
BHS,Bahamas,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,20
BHS,Bahamas,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,27
BHS,Bahamas,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12
BHS,Bahamas,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12
BHS,Bahamas,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33
BHS,Bahamas,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
BHS,Bahamas,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,18
BHS,Bahamas,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
BHS,Bahamas,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,10
BHS,Bahamas,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
BHS,Bahamas,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
BHS,Bahamas,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
BHS,Bahamas,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
BHS,Bahamas,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6
BHS,Bahamas,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12
BHS,Bahamas,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,27
BHS,Bahamas,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,52
BHS,Bahamas,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,18
BHS,Bahamas,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,5
BHS,Bahamas,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7
BHS,Bahamas,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,10
BHS,Bahamas,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23
BHS,Bahamas,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8
BLZ,Belize,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
BLZ,Belize,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
BLZ,Belize,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59
BLZ,Belize,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
BLZ,Belize,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,53
BLZ,Belize,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9
BLZ,Belize,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,54
BLZ,Belize,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
BLZ,Belize,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
BLZ,Belize,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
BLZ,Belize,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12
BLZ,Belize,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5
BLZ,Belize,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
BLZ,Belize,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,62
BLZ,Belize,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,76
BLZ,Belize,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,25
BLZ,Belize,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59
BOL,Bolivia (Plurinational State of),2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,72
BOL,Bolivia (Plurinational State of),2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
BOL,Bolivia (Plurinational State of),2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
BOL,Bolivia (Plurinational State of),2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
BOL,Bolivia (Plurinational State of),2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
BOL,Bolivia (Plurinational State of),2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,72
BOL,Bolivia (Plurinational State of),2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
BOL,Bolivia (Plurinational State of),2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
BOL,Bolivia (Plurinational State of),2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
BOL,Bolivia (Plurinational State of),2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23
BOL,Bolivia (Plurinational State of),2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
BOL,Bolivia (Plurinational State of),2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
BOL,Bolivia (Plurinational State of),2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
BOL,Bolivia (Plurinational State of),2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
BOL,Bolivia (Plurinational State of),2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
BOL,Bolivia (Plurinational State of),2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
BOL,Bolivia (Plurinational State of),2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
BOL,Bolivia (Plurinational State of),2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
BRA,Brazil,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
BRA,Brazil,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
BRA,Brazil,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
BRA,Brazil,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
BRA,Brazil,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
BRA,Brazil,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
BRA,Brazil,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
BRA,Brazil,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
BRA,Brazil,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
BRA,Brazil,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,60
BRA,Brazil,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,49
BRA,Brazil,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
BRA,Brazil,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
BRA,Brazil,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67
BRA,Brazil,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67
BRA,Brazil,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
BRA,Brazil,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67
BRA,Brazil,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,69
BRA,Brazil,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,97
BRA,Brazil,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
BRA,Brazil,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
BRA,Brazil,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
BRA,Brazil,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
BRA,Brazil,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
BRA,Brazil,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
BRA,Brazil,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
BRA,Brazil,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
BRA,Brazil,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
BRA,Brazil,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
BRA,Brazil,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
BRA,Brazil,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,65
BRA,Brazil,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
BRB,Barbados,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22
BRB,Barbados,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
BRB,Barbados,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
BRB,Barbados,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
BRB,Barbados,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
BRB,Barbados,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
BRB,Barbados,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,60
BRB,Barbados,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38
BRB,Barbados,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
BRB,Barbados,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
BRB,Barbados,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31
BRB,Barbados,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,15
BRB,Barbados,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,15
BRB,Barbados,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,26
BRB,Barbados,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28
BRB,Barbados,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
BRB,Barbados,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27
BRB,Barbados,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,15
BRB,Barbados,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,21
BRB,Barbados,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,76
BRB,Barbados,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
BRB,Barbados,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,39
BRB,Barbados,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,65
BRB,Barbados,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8
BRB,Barbados,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,31
BRB,Barbados,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,16
BRB,Barbados,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,16
BRB,Barbados,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,27
BRN,Brunei Darussalam,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
BRN,Brunei Darussalam,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
BRN,Brunei Darussalam,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
BRN,Brunei Darussalam,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
BRN,Brunei Darussalam,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
BRN,Brunei Darussalam,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
BRN,Brunei Darussalam,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
BRN,Brunei Darussalam,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
BRN,Brunei Darussalam,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
BRN,Brunei Darussalam,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
BRN,Brunei Darussalam,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
BRN,Brunei Darussalam,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
BRN,Brunei Darussalam,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,85
BRN,Brunei Darussalam,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
BRN,Brunei Darussalam,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,76
BRN,Brunei Darussalam,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,85
BRN,Brunei Darussalam,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
BRN,Brunei Darussalam,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,88
BRN,Brunei Darussalam,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
BRN,Brunei Darussalam,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,81
BRN,Brunei Darussalam,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,84
BRN,Brunei Darussalam,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
BRN,Brunei Darussalam,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
BRN,Brunei Darussalam,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
BRN,Brunei Darussalam,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
BRN,Brunei Darussalam,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
BRN,Brunei Darussalam,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
BRN,Brunei Darussalam,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
BRN,Brunei Darussalam,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
BRN,Brunei Darussalam,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
BRN,Brunei Darussalam,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
BRN,Brunei Darussalam,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
BRN,Brunei Darussalam,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
BRN,Brunei Darussalam,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,98
BRN,Brunei Darussalam,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
BRN,Brunei Darussalam,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,81
BRN,Brunei Darussalam,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,77
BRN,Brunei Darussalam,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
BRN,Brunei Darussalam,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
BRN,Brunei Darussalam,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
BRN,Brunei Darussalam,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
BRN,Brunei Darussalam,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,88
BRN,Brunei Darussalam,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,88
BRN,Brunei Darussalam,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,81
BTN,Bhutan,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
BTN,Bhutan,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
BTN,Bhutan,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
BTN,Bhutan,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
BTN,Bhutan,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,98
BTN,Bhutan,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,97
BTN,Bhutan,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,96
BTN,Bhutan,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,95
BTN,Bhutan,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,95
BTN,Bhutan,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
BTN,Bhutan,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
BTN,Bhutan,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
BTN,Bhutan,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
BTN,Bhutan,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,95
BTN,Bhutan,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
BTN,Bhutan,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
BTN,Bhutan,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
BTN,Bhutan,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,94
BTN,Bhutan,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,94
BTN,Bhutan,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,95
BTN,Bhutan,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,94
BTN,Bhutan,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,94
BTN,Bhutan,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
BTN,Bhutan,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
BTN,Bhutan,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90
BTN,Bhutan,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
BTN,Bhutan,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
BTN,Bhutan,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
BTN,Bhutan,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,92
BTN,Bhutan,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
BTN,Bhutan,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
BTN,Bhutan,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
BTN,Bhutan,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98
BTN,Bhutan,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,96
BTN,Bhutan,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,95
BTN,Bhutan,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,95
BTN,Bhutan,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,95
BTN,Bhutan,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
BTN,Bhutan,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,90
BTN,Bhutan,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,90
BTN,Bhutan,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,96
BTN,Bhutan,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
BTN,Bhutan,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,76
BTN,Bhutan,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
BTN,Bhutan,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
BTN,Bhutan,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
BTN,Bhutan,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
BTN,Bhutan,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
BTN,Bhutan,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
BTN,Bhutan,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
BWA,Botswana,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
BWA,Botswana,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
BWA,Botswana,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
BWA,Botswana,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
BWA,Botswana,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
BWA,Botswana,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
BWA,Botswana,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
BWA,Botswana,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,14
BWA,Botswana,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
BWA,Botswana,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
BWA,Botswana,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
BWA,Botswana,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
BWA,Botswana,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
BWA,Botswana,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
BWA,Botswana,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21
BWA,Botswana,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20
BWA,Botswana,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,35
BWA,Botswana,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
BWA,Botswana,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,93
BWA,Botswana,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
BWA,Botswana,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,79
BWA,Botswana,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,68
BWA,Botswana,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
BWA,Botswana,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,17
BWA,Botswana,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,45
BWA,Botswana,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
BWA,Botswana,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
BWA,Botswana,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
BWA,Botswana,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,50
BWA,Botswana,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,21
CAN,Canada,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
CAN,Canada,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
CAN,Canada,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
CAN,Canada,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
CAN,Canada,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
CAN,Canada,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
CAN,Canada,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
CAN,Canada,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
CAN,Canada,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
CAN,Canada,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
CAN,Canada,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
CAN,Canada,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
CAN,Canada,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,75
CAN,Canada,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,79
CAN,Canada,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
CAN,Canada,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
CAN,Canada,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
CAN,Canada,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
CAN,Canada,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
CAN,Canada,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,86
CAN,Canada,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73
CAN,Canada,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
CAN,Canada,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
CAN,Canada,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,79
CAN,Canada,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
CAN,Canada,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
CAN,Canada,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
CAN,Canada,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
CAN,Canada,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
CAN,Canada,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
CAN,Canada,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
CAN,Canada,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
CAN,Canada,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
CAN,Canada,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,79
CAN,Canada,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
CAN,Canada,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
CAN,Canada,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
CAN,Canada,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
CAN,Canada,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
CAN,Canada,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,86
CHE,Switzerland,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,26
CHE,Switzerland,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
CHE,Switzerland,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
CHE,Switzerland,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
CHE,Switzerland,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59
CHE,Switzerland,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59
CHE,Switzerland,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59
CHE,Switzerland,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
CHE,Switzerland,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
CHE,Switzerland,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
CHE,Switzerland,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
CHE,Switzerland,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
CHE,Switzerland,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
CHE,Switzerland,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20
CHE,Switzerland,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
CHE,Switzerland,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
CHE,Switzerland,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
CHE,Switzerland,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
CHE,Switzerland,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
CHE,Switzerland,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
CHE,Switzerland,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
CHE,Switzerland,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
CHE,Switzerland,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
CHE,Switzerland,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
CHE,Switzerland,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
CHE,Switzerland,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
CHE,Switzerland,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,26
CHE,Switzerland,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
CHE,Switzerland,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
CHE,Switzerland,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
CHE,Switzerland,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
CHE,Switzerland,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
CHE,Switzerland,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
CHE,Switzerland,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64
CHE,Switzerland,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64
CHE,Switzerland,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64
CHE,Switzerland,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
CHE,Switzerland,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
CHE,Switzerland,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
CHE,Switzerland,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,20
CHE,Switzerland,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,51
CHE,Switzerland,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,51
CHE,Switzerland,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,51
CHE,Switzerland,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,56
CHE,Switzerland,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,56
CHE,Switzerland,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,56
CHE,Switzerland,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59
CHE,Switzerland,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59
CHE,Switzerland,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59
CHE,Switzerland,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
CHE,Switzerland,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
CHE,Switzerland,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
CHL,Chile,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
CHL,Chile,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
CHL,Chile,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
CHL,Chile,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
CHL,Chile,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
CHL,Chile,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
CHL,Chile,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
CHL,Chile,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
CHL,Chile,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
CHL,Chile,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
CHL,Chile,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
CHL,Chile,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
CHL,Chile,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
CHL,Chile,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,84
CHL,Chile,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,76
CHL,Chile,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
CHL,Chile,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,69
CHL,Chile,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
CHL,Chile,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
CHL,Chile,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
CHL,Chile,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
CHL,Chile,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
CHL,Chile,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
CIV,Cote d'Ivoire,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
CIV,Cote d'Ivoire,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
CIV,Cote d'Ivoire,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,32
CIV,Cote d'Ivoire,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46
CIV,Cote d'Ivoire,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12
CIV,Cote d'Ivoire,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38
CIV,Cote d'Ivoire,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
CMR,Cameroon,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,5
CMR,Cameroon,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,20
CMR,Cameroon,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23
CMR,Cameroon,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5
CMR,Cameroon,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
COK,Cook Islands,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
COK,Cook Islands,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
COK,Cook Islands,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
COK,Cook Islands,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,95
COK,Cook Islands,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
COK,Cook Islands,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38
COK,Cook Islands,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,97
COK,Cook Islands,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,97
COK,Cook Islands,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,14
COK,Cook Islands,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
COK,Cook Islands,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,48
COK,Cook Islands,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
COK,Cook Islands,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
COK,Cook Islands,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,41
COK,Cook Islands,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,69
COK,Cook Islands,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,70
COK,Cook Islands,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
COK,Cook Islands,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
COK,Cook Islands,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
COK,Cook Islands,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,44
COK,Cook Islands,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46
COK,Cook Islands,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,45
COK,Cook Islands,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,57
COK,Cook Islands,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
COK,Cook Islands,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
COK,Cook Islands,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98
COK,Cook Islands,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
COK,Cook Islands,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
COK,Cook Islands,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,44
COK,Cook Islands,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,45
COK,Cook Islands,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,45
COK,Cook Islands,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,53
COK,Cook Islands,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
COK,Cook Islands,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
COK,Cook Islands,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,97
COK,Cook Islands,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,86
COK,Cook Islands,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34
COL,Colombia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
COL,Colombia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
COL,Colombia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
COL,Colombia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,27
COL,Colombia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
COL,Colombia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,16
COL,Colombia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29
COL,Colombia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,31
COL,Colombia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29
COL,Colombia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,39
COL,Colombia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
COL,Colombia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
COL,Colombia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
COL,Colombia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
COL,Colombia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
COL,Colombia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
COL,Colombia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3
COL,Colombia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9
COL,Colombia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,10
COL,Colombia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9
COL,Colombia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11
COL,Colombia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11
COL,Colombia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
COL,Colombia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
COL,Colombia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
COL,Colombia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,95
COL,Colombia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
COL,Colombia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
COL,Colombia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
COL,Colombia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,49
COL,Colombia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,42
COL,Colombia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,62
COL,Colombia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
COL,Colombia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
COL,Colombia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
COL,Colombia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
COL,Colombia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59
COL,Colombia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34
COL,Colombia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,24
COL,Colombia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,24
CPV,Cabo Verde,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
CPV,Cabo Verde,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
CPV,Cabo Verde,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,93
CRI,Costa Rica,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,98
CRI,Costa Rica,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
CRI,Costa Rica,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
CRI,Costa Rica,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
CRI,Costa Rica,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,39
CRI,Costa Rica,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
CRI,Costa Rica,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,57
CRI,Costa Rica,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
CYP,Cyprus,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
CYP,Cyprus,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,58
CYP,Cyprus,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59
CYP,Cyprus,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
CYP,Cyprus,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
CYP,Cyprus,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
CYP,Cyprus,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,57
CYP,Cyprus,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
CYP,Cyprus,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
CYP,Cyprus,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,84
CYP,Cyprus,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,84
CYP,Cyprus,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,52
CYP,Cyprus,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
CYP,Cyprus,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
CYP,Cyprus,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
CYP,Cyprus,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73
CYP,Cyprus,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,54
CYP,Cyprus,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59
CYP,Cyprus,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
CYP,Cyprus,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
CYP,Cyprus,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
DEU,Germany,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,40
DEU,Germany,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,40
DEU,Germany,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,41
DEU,Germany,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,43
DEU,Germany,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
DEU,Germany,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,48
DEU,Germany,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,52
DEU,Germany,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
DEU,Germany,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,58
DEU,Germany,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
DEU,Germany,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
DEU,Germany,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
DEU,Germany,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
DEU,Germany,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27
DEU,Germany,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27
DEU,Germany,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27
DEU,Germany,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29
DEU,Germany,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31
DEU,Germany,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
DEU,Germany,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,37
DEU,Germany,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,40
DEU,Germany,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
DEU,Germany,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
DEU,Germany,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
DEU,Germany,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
DEU,Germany,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
DEU,Germany,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,40
DEU,Germany,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,40
DEU,Germany,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,41
DEU,Germany,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,43
DEU,Germany,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,45
DEU,Germany,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,48
DEU,Germany,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,52
DEU,Germany,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,55
DEU,Germany,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
DEU,Germany,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63
DEU,Germany,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
DEU,Germany,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
DEU,Germany,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
DEU,Germany,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,27
DEU,Germany,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,27
DEU,Germany,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,27
DEU,Germany,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29
DEU,Germany,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,31
DEU,Germany,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,33
DEU,Germany,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,37
DEU,Germany,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,40
DEU,Germany,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
DEU,Germany,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,47
DEU,Germany,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,51
DEU,Germany,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,54
DEU,Germany,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,54
DMA,Dominica,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
DMA,Dominica,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
DMA,Dominica,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
DMA,Dominica,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
DMA,Dominica,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
DMA,Dominica,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,69
DMA,Dominica,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
DNK,Denmark,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
DNK,Denmark,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
DNK,Denmark,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
DNK,Denmark,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
DNK,Denmark,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
DNK,Denmark,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
DNK,Denmark,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,58
DNK,Denmark,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
DNK,Denmark,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
DNK,Denmark,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
DNK,Denmark,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
DNK,Denmark,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
DNK,Denmark,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
DNK,Denmark,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
DNK,Denmark,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,75
DNK,Denmark,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
DNK,Denmark,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
DNK,Denmark,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,16
DNK,Denmark,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
DNK,Denmark,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
DNK,Denmark,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,62
DNK,Denmark,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
DNK,Denmark,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
DNK,Denmark,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
DNK,Denmark,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
DNK,Denmark,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
DNK,Denmark,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
DNK,Denmark,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
DNK,Denmark,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
DNK,Denmark,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
DNK,Denmark,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
DNK,Denmark,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
DNK,Denmark,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
DNK,Denmark,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
DNK,Denmark,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
DNK,Denmark,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
DNK,Denmark,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
DNK,Denmark,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,70
DNK,Denmark,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
DNK,Denmark,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
DNK,Denmark,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,77
DNK,Denmark,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,79
DNK,Denmark,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
DNK,Denmark,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
DNK,Denmark,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,76
DNK,Denmark,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
DNK,Denmark,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
DNK,Denmark,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,81
DNK,Denmark,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
DNK,Denmark,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
DOM,Dominican Republic,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59
DOM,Dominican Republic,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
DOM,Dominican Republic,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,10
DOM,Dominican Republic,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11
DOM,Dominican Republic,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,26
DOM,Dominican Republic,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30
DOM,Dominican Republic,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
DOM,Dominican Republic,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30
DOM,Dominican Republic,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6
DOM,Dominican Republic,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
DOM,Dominican Republic,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
DOM,Dominican Republic,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,13
DOM,Dominican Republic,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,65
DOM,Dominican Republic,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,40
ECU,Ecuador,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
ECU,Ecuador,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
ECU,Ecuador,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
ECU,Ecuador,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
ECU,Ecuador,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,98
ECU,Ecuador,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
ECU,Ecuador,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
ECU,Ecuador,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29
ECU,Ecuador,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,98
ECU,Ecuador,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,81
ECU,Ecuador,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
ECU,Ecuador,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,95
ECU,Ecuador,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,86
ECU,Ecuador,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
ECU,Ecuador,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
ECU,Ecuador,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35
ECU,Ecuador,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
ECU,Ecuador,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
ECU,Ecuador,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
ECU,Ecuador,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
ECU,Ecuador,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
ECU,Ecuador,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
ECU,Ecuador,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
ECU,Ecuador,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,81
ECU,Ecuador,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
ECU,Ecuador,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
ECU,Ecuador,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,99
ECU,Ecuador,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,95
ERI,Eritrea,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
ESP,Spain,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59
ESP,Spain,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
ESP,Spain,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,69
ESP,Spain,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
ESP,Spain,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
ESP,Spain,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
ESP,Spain,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
ESP,Spain,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
ESP,Spain,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
ESP,Spain,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
ESP,Spain,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
ESP,Spain,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
ESP,Spain,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
ESP,Spain,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,62
ESP,Spain,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
ESP,Spain,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
ESP,Spain,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
ESP,Spain,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
ESP,Spain,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,79
ESP,Spain,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
ESP,Spain,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
ESP,Spain,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
ESP,Spain,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,79
ESP,Spain,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,79
ESP,Spain,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
ESP,Spain,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,81
ESP,Spain,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,55
ESP,Spain,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
ESP,Spain,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,57
ESP,Spain,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
ESP,Spain,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,65
ESP,Spain,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,68
ESP,Spain,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,69
ESP,Spain,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,70
ESP,Spain,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
ESP,Spain,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
ESP,Spain,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
ESP,Spain,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
ESP,Spain,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
ESP,Spain,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,58
ESP,Spain,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
ESP,Spain,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
ESP,Spain,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
ESP,Spain,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
ESP,Spain,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
ESP,Spain,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
ESP,Spain,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
ESP,Spain,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,76
ESP,Spain,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
ESP,Spain,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,86
EST,Estonia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,52
EST,Estonia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
EST,Estonia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,60
EST,Estonia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
EST,Estonia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,52
EST,Estonia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46
EST,Estonia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
EST,Estonia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
EST,Estonia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
EST,Estonia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
EST,Estonia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
EST,Estonia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
EST,Estonia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,61
EST,Estonia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
EST,Estonia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,48
EST,Estonia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59
EST,Estonia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
EST,Estonia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
ETH,Ethiopia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
ETH,Ethiopia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
ETH,Ethiopia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
ETH,Ethiopia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
ETH,Ethiopia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
ETH,Ethiopia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
ETH,Ethiopia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
ETH,Ethiopia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
ETH,Ethiopia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
ETH,Ethiopia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
ETH,Ethiopia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
ETH,Ethiopia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,92
ETH,Ethiopia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
ETH,Ethiopia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84
ETH,Ethiopia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
ETH,Ethiopia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
ETH,Ethiopia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
FIN,Finland,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,69
FIN,Finland,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
FIN,Finland,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
FIN,Finland,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,69
FIN,Finland,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
FIN,Finland,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
FIN,Finland,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
FIN,Finland,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
FIN,Finland,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
FIN,Finland,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
FIN,Finland,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,62
FIN,Finland,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,60
FIN,Finland,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
FIN,Finland,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
FIN,Finland,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
FIN,Finland,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
FIN,Finland,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
FIN,Finland,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
FIN,Finland,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
FIN,Finland,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73
FIN,Finland,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
FIN,Finland,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
FIN,Finland,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
FIN,Finland,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,76
FIN,Finland,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
FIN,Finland,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,61
FIN,Finland,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,62
FIN,Finland,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,61
FIN,Finland,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
FIN,Finland,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
FIN,Finland,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
FIN,Finland,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
FIN,Finland,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
FIN,Finland,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
FJI,Fiji,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
FJI,Fiji,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
FJI,Fiji,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
FJI,Fiji,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
FJI,Fiji,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
FJI,Fiji,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
FJI,Fiji,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
FJI,Fiji,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,98
FJI,Fiji,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
FJI,Fiji,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
FJI,Fiji,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,53
FJI,Fiji,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
FJI,Fiji,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,60
FJI,Fiji,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
FJI,Fiji,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
FJI,Fiji,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
FJI,Fiji,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
FJI,Fiji,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,89
FJI,Fiji,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
FJI,Fiji,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,49
FJI,Fiji,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
FJI,Fiji,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
FJI,Fiji,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
FJI,Fiji,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
FJI,Fiji,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
FJI,Fiji,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
FJI,Fiji,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
FJI,Fiji,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
FJI,Fiji,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,55
FJI,Fiji,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
FJI,Fiji,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,61
FJI,Fiji,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,48
FJI,Fiji,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,52
FJI,Fiji,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,46
FJI,Fiji,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,53
FJI,Fiji,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,53
FRA,France,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29
FRA,France,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29
FRA,France,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,21
FRA,France,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,20
FRA,France,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19
FRA,France,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,21
FRA,France,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,24
FRA,France,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,26
FRA,France,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29
FRA,France,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35
FRA,France,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,41
FRA,France,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46
FRA,France,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,48
FRA,France,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,25
FRA,France,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22
FRA,France,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
FRA,France,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,16
FRA,France,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,13
FRA,France,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20
FRA,France,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21
FRA,France,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24
FRA,France,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24
FRA,France,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
FRA,France,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,37
FRA,France,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,37
FRA,France,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,42
FRA,France,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29
FRA,France,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29
FRA,France,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,21
FRA,France,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,20
FRA,France,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,19
FRA,France,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,21
FRA,France,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,24
FRA,France,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,26
FRA,France,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29
FRA,France,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,35
FRA,France,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,41
FRA,France,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46
FRA,France,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,48
FRA,France,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,25
FRA,France,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,22
FRA,France,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,17
FRA,France,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,16
FRA,France,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,13
FRA,France,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,20
FRA,France,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,21
FRA,France,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,24
FRA,France,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,24
FRA,France,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,33
FRA,France,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,37
FRA,France,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,37
FRA,France,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,42
FSM,Micronesia (Federated States of),2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
FSM,Micronesia (Federated States of),2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
FSM,Micronesia (Federated States of),2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
FSM,Micronesia (Federated States of),2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
FSM,Micronesia (Federated States of),2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
FSM,Micronesia (Federated States of),2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
FSM,Micronesia (Federated States of),2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
FSM,Micronesia (Federated States of),2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,62
FSM,Micronesia (Federated States of),2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
FSM,Micronesia (Federated States of),2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
FSM,Micronesia (Federated States of),2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28
FSM,Micronesia (Federated States of),2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32
FSM,Micronesia (Federated States of),2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,70
FSM,Micronesia (Federated States of),2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,68
FSM,Micronesia (Federated States of),2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,76
FSM,Micronesia (Federated States of),2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
FSM,Micronesia (Federated States of),2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,57
GBR,United Kingdom,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
GBR,United Kingdom,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
GBR,United Kingdom,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
GBR,United Kingdom,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
GBR,United Kingdom,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
GBR,United Kingdom,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
GBR,United Kingdom,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
GBR,United Kingdom,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
GBR,United Kingdom,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
GBR,United Kingdom,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
GBR,United Kingdom,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
GBR,United Kingdom,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
GBR,United Kingdom,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
GBR,United Kingdom,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
GBR,United Kingdom,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
GBR,United Kingdom,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,88
GBR,United Kingdom,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,86
GBR,United Kingdom,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,86
GBR,United Kingdom,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,84
GBR,United Kingdom,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
GBR,United Kingdom,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
GBR,United Kingdom,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,81
GBR,United Kingdom,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,81
GBR,United Kingdom,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
GBR,United Kingdom,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
GBR,United Kingdom,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
GBR,United Kingdom,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
GBR,United Kingdom,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
GBR,United Kingdom,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
GBR,United Kingdom,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
GBR,United Kingdom,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
GBR,United Kingdom,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
GBR,United Kingdom,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
GBR,United Kingdom,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
GBR,United Kingdom,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
GBR,United Kingdom,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
GBR,United Kingdom,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
GBR,United Kingdom,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
GBR,United Kingdom,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,81
GBR,United Kingdom,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
GBR,United Kingdom,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84
GBR,United Kingdom,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
GBR,United Kingdom,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,86
GBR,United Kingdom,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,86
GBR,United Kingdom,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
GBR,United Kingdom,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84
GBR,United Kingdom,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84
GBR,United Kingdom,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84
GBR,United Kingdom,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
GBR,United Kingdom,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
GEO,Georgia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,39
GEO,Georgia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19
GEO,Georgia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34
GEO,Georgia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,48
GEO,Georgia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12
GEO,Georgia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22
GEO,Georgia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31
GEO,Georgia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
GMB,Gambia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,60
GMB,Gambia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30
GMB,Gambia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
GMB,Gambia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27
GMB,Gambia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
GMB,Gambia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,57
GMB,Gambia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64
GMB,Gambia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
GMB,Gambia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
GMB,Gambia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,31
GMB,Gambia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,28
GRD,Grenada,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
GRD,Grenada,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
GRD,Grenada,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1
GRD,Grenada,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,13
GRD,Grenada,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,37
GRD,Grenada,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28
GRD,Grenada,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1
GRD,Grenada,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5
GTM,Guatemala,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
GTM,Guatemala,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,42
GTM,Guatemala,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35
GTM,Guatemala,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36
GTM,Guatemala,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,26
GTM,Guatemala,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32
GTM,Guatemala,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27
GTM,Guatemala,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
GTM,Guatemala,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24
GTM,Guatemala,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,18
GTM,Guatemala,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,47
GTM,Guatemala,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
GTM,Guatemala,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,28
GTM,Guatemala,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
GUY,Guyana,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,14
GUY,Guyana,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19
GUY,Guyana,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
GUY,Guyana,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2
GUY,Guyana,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,15
GUY,Guyana,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30
GUY,Guyana,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33
GUY,Guyana,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38
GUY,Guyana,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,32
GUY,Guyana,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3
GUY,Guyana,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22
GUY,Guyana,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
GUY,Guyana,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,10
GUY,Guyana,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5
GUY,Guyana,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3
GUY,Guyana,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
GUY,Guyana,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12
GUY,Guyana,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,19
GUY,Guyana,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,19
GUY,Guyana,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,25
GUY,Guyana,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
GUY,Guyana,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12
GUY,Guyana,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,34
GUY,Guyana,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,40
GUY,Guyana,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,44
GUY,Guyana,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,13
GUY,Guyana,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,18
GUY,Guyana,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,22
HND,Honduras,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
HND,Honduras,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
HND,Honduras,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
HND,Honduras,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
HND,Honduras,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
HND,Honduras,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,72
HND,Honduras,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
HND,Honduras,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
HND,Honduras,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
HND,Honduras,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
HND,Honduras,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
HND,Honduras,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46
HND,Honduras,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
HND,Honduras,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
HND,Honduras,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
HND,Honduras,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
HND,Honduras,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
HND,Honduras,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,52
HND,Honduras,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
HND,Honduras,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,57
HUN,Hungary,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
HUN,Hungary,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
HUN,Hungary,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
HUN,Hungary,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
HUN,Hungary,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
HUN,Hungary,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
HUN,Hungary,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
HUN,Hungary,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
HUN,Hungary,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
HUN,Hungary,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,75
HUN,Hungary,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
HUN,Hungary,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
HUN,Hungary,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
HUN,Hungary,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,76
HUN,Hungary,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
HUN,Hungary,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
HUN,Hungary,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
HUN,Hungary,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
HUN,Hungary,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
HUN,Hungary,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73
HUN,Hungary,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
HUN,Hungary,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,76
HUN,Hungary,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,80
HUN,Hungary,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
HUN,Hungary,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
HUN,Hungary,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
HUN,Hungary,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
HUN,Hungary,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
HUN,Hungary,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
IDN,Indonesia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,5
IDN,Indonesia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
IDN,Indonesia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
IDN,Indonesia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8
IDN,Indonesia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
IDN,Indonesia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29
IDN,Indonesia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3
IDN,Indonesia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5
IDN,Indonesia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6
IDN,Indonesia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
IDN,Indonesia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
IDN,Indonesia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
IDN,Indonesia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,5
IDN,Indonesia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6
IDN,Indonesia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6
IDN,Indonesia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3
IDN,Indonesia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,5
IDN,Indonesia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6
IRL,Ireland,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
IRL,Ireland,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
IRL,Ireland,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
IRL,Ireland,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
IRL,Ireland,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
IRL,Ireland,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
IRL,Ireland,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
IRL,Ireland,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,69
IRL,Ireland,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
IRL,Ireland,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
IRL,Ireland,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,61
IRL,Ireland,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
IRL,Ireland,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
IRL,Ireland,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
IRL,Ireland,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,86
IRL,Ireland,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,86
IRL,Ireland,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,84
IRL,Ireland,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
IRL,Ireland,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
IRL,Ireland,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
IRL,Ireland,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65
IRL,Ireland,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
IRL,Ireland,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,79
IRL,Ireland,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
IRL,Ireland,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,79
IRL,Ireland,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
IRL,Ireland,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
IRL,Ireland,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,92
IRL,Ireland,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
IRL,Ireland,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
IRL,Ireland,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,65
IRL,Ireland,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
IRL,Ireland,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
IRL,Ireland,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
IRL,Ireland,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
IRL,Ireland,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
IRL,Ireland,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
IRL,Ireland,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,88
IRL,Ireland,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
IRL,Ireland,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,58
IRL,Ireland,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
IRL,Ireland,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
IRL,Ireland,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
ISL,Iceland,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
ISL,Iceland,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
ISL,Iceland,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
ISL,Iceland,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
ISL,Iceland,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
ISL,Iceland,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
ISL,Iceland,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
ISL,Iceland,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
ISL,Iceland,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
ISL,Iceland,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
ISL,Iceland,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
ISL,Iceland,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
ISL,Iceland,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,92
ISL,Iceland,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
ISL,Iceland,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,88
ISL,Iceland,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,89
ISL,Iceland,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
ISL,Iceland,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
ISL,Iceland,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,85
ISL,Iceland,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,93
ISL,Iceland,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90
ISL,Iceland,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90
ISL,Iceland,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,85
ISL,Iceland,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
ISL,Iceland,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
ISL,Iceland,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
ISL,Iceland,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
ISL,Iceland,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
ISL,Iceland,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
ISL,Iceland,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
ISL,Iceland,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
ISL,Iceland,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,94
ISL,Iceland,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98
ISL,Iceland,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,91
ISL,Iceland,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,92
ISL,Iceland,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
ISL,Iceland,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,88
ISL,Iceland,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,88
ISL,Iceland,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,89
ISL,Iceland,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,86
ISL,Iceland,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
ISL,Iceland,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,91
ISL,Iceland,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
ISR,Israel,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,54
ISR,Israel,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
ISR,Israel,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
ISR,Israel,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,52
ISR,Israel,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
ISR,Israel,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,58
ISR,Israel,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,61
ISR,Israel,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
ISR,Israel,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
ISR,Israel,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
ISR,Israel,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
ISR,Israel,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,57
ISR,Israel,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
ISR,Israel,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
ISR,Israel,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
ISR,Israel,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
ISR,Israel,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
ISR,Israel,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,57
ISR,Israel,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,54
ISR,Israel,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63
ISR,Israel,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,62
ISR,Israel,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,52
ISR,Israel,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,55
ISR,Israel,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
ISR,Israel,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
ISR,Israel,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,51
ISR,Israel,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,52
ISR,Israel,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,57
ISR,Israel,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,50
ISR,Israel,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,52
ISR,Israel,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,54
ISR,Israel,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,58
ITA,Italy,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
ITA,Italy,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
ITA,Italy,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
ITA,Italy,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
ITA,Italy,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
ITA,Italy,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
ITA,Italy,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
ITA,Italy,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
ITA,Italy,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
ITA,Italy,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
ITA,Italy,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
ITA,Italy,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,53
ITA,Italy,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,58
ITA,Italy,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
ITA,Italy,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
ITA,Italy,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
ITA,Italy,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
ITA,Italy,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
ITA,Italy,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
ITA,Italy,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,53
ITA,Italy,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
ITA,Italy,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,41
ITA,Italy,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,53
ITA,Italy,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27
ITA,Italy,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32
ITA,Italy,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,39
ITA,Italy,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12
ITA,Italy,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,41
ITA,Italy,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
ITA,Italy,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
ITA,Italy,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
ITA,Italy,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
ITA,Italy,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73
ITA,Italy,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73
ITA,Italy,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
ITA,Italy,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
ITA,Italy,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
ITA,Italy,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,77
ITA,Italy,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,77
ITA,Italy,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,10
ITA,Italy,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,38
ITA,Italy,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
ITA,Italy,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
ITA,Italy,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
ITA,Italy,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
ITA,Italy,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
ITA,Italy,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
ITA,Italy,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
ITA,Italy,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,62
ITA,Italy,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,61
ITA,Italy,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
ITA,Italy,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,61
JAM,Jamaica,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,24
JAM,Jamaica,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,24
JAM,Jamaica,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23
JAM,Jamaica,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9
JAM,Jamaica,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1
JAM,Jamaica,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4
JAM,Jamaica,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
JAM,Jamaica,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9
JAM,Jamaica,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
JAM,Jamaica,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
JAM,Jamaica,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
JAM,Jamaica,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,21
JAM,Jamaica,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29
JAM,Jamaica,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,21
JAM,Jamaica,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6
JAM,Jamaica,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,16
JAM,Jamaica,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,16
JPN,Japan,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,17
JPN,Japan,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1
JPN,Japan,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1
JPN,Japan,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
JPN,Japan,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1
JPN,Japan,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
JPN,Japan,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
JPN,Japan,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1
JPN,Japan,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2
JPN,Japan,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8
JPN,Japan,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,15
JPN,Japan,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1
JPN,Japan,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1
JPN,Japan,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
JPN,Japan,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
JPN,Japan,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
JPN,Japan,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
JPN,Japan,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1
JPN,Japan,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
JPN,Japan,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
JPN,Japan,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1
JPN,Japan,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,9
JPN,Japan,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,5
JPN,Japan,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1
JPN,Japan,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,0
JPN,Japan,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,0
JPN,Japan,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,0
JPN,Japan,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,0
JPN,Japan,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12
JPN,Japan,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,5
JPN,Japan,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6
JPN,Japan,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2
JPN,Japan,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,0
JPN,Japan,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,0
JPN,Japan,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,0
JPN,Japan,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,0
JPN,Japan,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,0
JPN,Japan,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,10
KEN,Kenya,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,25
KEN,Kenya,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34
KEN,Kenya,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29
KEN,Kenya,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,26
KEN,Kenya,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,16
KEN,Kenya,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
KEN,Kenya,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
KEN,Kenya,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29
KEN,Kenya,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,17
KGZ,Kyrgyzstan,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
KNA,Saint Kitts and Nevis,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
KNA,Saint Kitts and Nevis,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,97
KNA,Saint Kitts and Nevis,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
KNA,Saint Kitts and Nevis,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
KNA,Saint Kitts and Nevis,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,98
KNA,Saint Kitts and Nevis,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,79
KNA,Saint Kitts and Nevis,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
KOR,Republic of Korea,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
KOR,Republic of Korea,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,31
KOR,Republic of Korea,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
KOR,Republic of Korea,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
KOR,Republic of Korea,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
KOR,Republic of Korea,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
KOR,Republic of Korea,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
KOR,Republic of Korea,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,49
KOR,Republic of Korea,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65
KOR,Republic of Korea,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
KOR,Republic of Korea,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
KOR,Republic of Korea,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
KOR,Republic of Korea,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65
KOR,Republic of Korea,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63
KOR,Republic of Korea,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
KOR,Republic of Korea,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
KOR,Republic of Korea,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
KOR,Republic of Korea,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,97
KOR,Republic of Korea,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,47
KOR,Republic of Korea,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
KOR,Republic of Korea,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
KOR,Republic of Korea,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
KOR,Republic of Korea,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
LAO,Lao People's Democratic Republic,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
LAO,Lao People's Democratic Republic,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38
LAO,Lao People's Democratic Republic,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
LAO,Lao People's Democratic Republic,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
LAO,Lao People's Democratic Republic,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,25
LAO,Lao People's Democratic Republic,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
LAO,Lao People's Democratic Republic,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
LAO,Lao People's Democratic Republic,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,41
LAO,Lao People's Democratic Republic,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,53
LBR,Liberia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,13
LBR,Liberia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,40
LBR,Liberia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,41
LBR,Liberia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,42
LBR,Liberia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
LBR,Liberia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28
LBR,Liberia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29
LCA,Saint Lucia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
LCA,Saint Lucia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,52
LCA,Saint Lucia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
LCA,Saint Lucia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
LCA,Saint Lucia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,42
LCA,Saint Lucia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67
LCA,Saint Lucia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
LCA,Saint Lucia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
LKA,Sri Lanka,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
LKA,Sri Lanka,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
LKA,Sri Lanka,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
LKA,Sri Lanka,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,69
LKA,Sri Lanka,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
LKA,Sri Lanka,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
LKA,Sri Lanka,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
LKA,Sri Lanka,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
LKA,Sri Lanka,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
LKA,Sri Lanka,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
LKA,Sri Lanka,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,49
LKA,Sri Lanka,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
LKA,Sri Lanka,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,41
LSO,Lesotho,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
LSO,Lesotho,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
LTU,Lithuania,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,18
LTU,Lithuania,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35
LTU,Lithuania,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
LTU,Lithuania,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
LTU,Lithuania,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
LTU,Lithuania,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,61
LTU,Lithuania,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,58
LTU,Lithuania,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28
LTU,Lithuania,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65
LTU,Lithuania,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
LTU,Lithuania,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
LTU,Lithuania,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
LTU,Lithuania,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
LTU,Lithuania,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,51
LTU,Lithuania,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
LTU,Lithuania,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
LTU,Lithuania,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,33
LTU,Lithuania,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
LTU,Lithuania,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
LUX,Luxembourg,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19
LUX,Luxembourg,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23
LUX,Luxembourg,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,24
LUX,Luxembourg,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,25
LUX,Luxembourg,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,25
LUX,Luxembourg,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
LUX,Luxembourg,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
LUX,Luxembourg,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
LUX,Luxembourg,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
LUX,Luxembourg,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
LUX,Luxembourg,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
LUX,Luxembourg,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
LUX,Luxembourg,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
LUX,Luxembourg,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,16
LUX,Luxembourg,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20
LUX,Luxembourg,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21
LUX,Luxembourg,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21
LUX,Luxembourg,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,10
LUX,Luxembourg,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
LUX,Luxembourg,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
LUX,Luxembourg,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
LUX,Luxembourg,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
LUX,Luxembourg,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
LUX,Luxembourg,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
LUX,Luxembourg,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
LUX,Luxembourg,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
LUX,Luxembourg,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,49
LUX,Luxembourg,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
LUX,Luxembourg,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46
LUX,Luxembourg,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,47
LUX,Luxembourg,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,52
LUX,Luxembourg,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,53
LUX,Luxembourg,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60
LUX,Luxembourg,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60
LUX,Luxembourg,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60
LUX,Luxembourg,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60
LUX,Luxembourg,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60
LUX,Luxembourg,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60
LUX,Luxembourg,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60
LUX,Luxembourg,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
LUX,Luxembourg,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,53
LUX,Luxembourg,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,41
LUX,Luxembourg,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,42
LUX,Luxembourg,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,47
LUX,Luxembourg,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,45
LUX,Luxembourg,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
LUX,Luxembourg,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
LUX,Luxembourg,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
LUX,Luxembourg,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
LUX,Luxembourg,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
LUX,Luxembourg,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
LUX,Luxembourg,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
LVA,Latvia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,49
LVA,Latvia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59
LVA,Latvia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
LVA,Latvia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,54
LVA,Latvia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,48
LVA,Latvia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
LVA,Latvia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,39
LVA,Latvia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46
LVA,Latvia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
LVA,Latvia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,53
LVA,Latvia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
LVA,Latvia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,61
LVA,Latvia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
LVA,Latvia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
LVA,Latvia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,48
LVA,Latvia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
LVA,Latvia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,48
LVA,Latvia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,25
LVA,Latvia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
LVA,Latvia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35
LVA,Latvia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38
LVA,Latvia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
LVA,Latvia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
LVA,Latvia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,57
LVA,Latvia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,62
LVA,Latvia,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,55
LVA,Latvia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
LVA,Latvia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,55
LVA,Latvia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
LVA,Latvia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,54
LVA,Latvia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,45
LVA,Latvia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,41
LVA,Latvia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46
LVA,Latvia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,47
LVA,Latvia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,53
LVA,Latvia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,61
LVA,Latvia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,51
LVA,Latvia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,57
LVA,Latvia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,49
LVA,Latvia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,26
LVA,Latvia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34
LVA,Latvia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,35
LVA,Latvia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,38
LVA,Latvia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,44
MDA,Republic of Moldova,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,61
MDA,Republic of Moldova,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
MDA,Republic of Moldova,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,50
MDA,Republic of Moldova,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,44
MDA,Republic of Moldova,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,41
MDA,Republic of Moldova,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,49
MDA,Republic of Moldova,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
MDA,Republic of Moldova,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
MDA,Republic of Moldova,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,39
MDA,Republic of Moldova,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
MDA,Republic of Moldova,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,58
MDA,Republic of Moldova,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,48
MDV,Maldives,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
MDV,Maldives,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
MDV,Maldives,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,58
MDV,Maldives,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
MDV,Maldives,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
MDV,Maldives,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,40
MDV,Maldives,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
MEX,Mexico,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
MEX,Mexico,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
MEX,Mexico,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
MEX,Mexico,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
MEX,Mexico,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
MEX,Mexico,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
MEX,Mexico,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
MEX,Mexico,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,44
MEX,Mexico,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,20
MEX,Mexico,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1
MEX,Mexico,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
MEX,Mexico,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
MEX,Mexico,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,92
MEX,Mexico,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
MEX,Mexico,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,96
MEX,Mexico,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
MEX,Mexico,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
MEX,Mexico,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,97
MEX,Mexico,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,85
MEX,Mexico,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5
MEX,Mexico,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1
MEX,Mexico,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
MEX,Mexico,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8
MEX,Mexico,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,11
MEX,Mexico,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,19
MEX,Mexico,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
MEX,Mexico,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
MEX,Mexico,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
MEX,Mexico,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
MEX,Mexico,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
MEX,Mexico,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
MEX,Mexico,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,14
MEX,Mexico,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,11
MEX,Mexico,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,12
MEX,Mexico,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,98
MEX,Mexico,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,95
MEX,Mexico,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,99
MEX,Mexico,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,98
MEX,Mexico,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,99
MEX,Mexico,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,99
MHL,Marshall Islands,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36
MHL,Marshall Islands,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,26
MHL,Marshall Islands,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,16
MHL,Marshall Islands,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
MHL,Marshall Islands,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46
MHL,Marshall Islands,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
MHL,Marshall Islands,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33
MHL,Marshall Islands,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
MHL,Marshall Islands,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
MHL,Marshall Islands,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
MHL,Marshall Islands,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
MHL,Marshall Islands,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
MHL,Marshall Islands,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
MHL,Marshall Islands,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,15
MHL,Marshall Islands,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21
MHL,Marshall Islands,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
MHL,Marshall Islands,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
MHL,Marshall Islands,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
MHL,Marshall Islands,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35
MHL,Marshall Islands,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
MHL,Marshall Islands,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23
MHL,Marshall Islands,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
MHL,Marshall Islands,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
MHL,Marshall Islands,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,49
MHL,Marshall Islands,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,13
MHL,Marshall Islands,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,28
MHL,Marshall Islands,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,43
MHL,Marshall Islands,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
MHL,Marshall Islands,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
MHL,Marshall Islands,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
MHL,Marshall Islands,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
MHL,Marshall Islands,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,51
MHL,Marshall Islands,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,93
MHL,Marshall Islands,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
MHL,Marshall Islands,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7
MHL,Marshall Islands,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,17
MHL,Marshall Islands,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,18
MHL,Marshall Islands,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,40
MHL,Marshall Islands,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,49
MHL,Marshall Islands,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,39
MHL,Marshall Islands,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,36
MHL,Marshall Islands,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,18
MHL,Marshall Islands,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23
MKD,North Macedonia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
MKD,North Macedonia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
MKD,North Macedonia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,41
MKD,North Macedonia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,49
MKD,North Macedonia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37
MKD,North Macedonia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
MKD,North Macedonia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,43
MKD,North Macedonia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
MKD,North Macedonia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
MKD,North Macedonia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
MKD,North Macedonia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,44
MKD,North Macedonia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30
MKD,North Macedonia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,44
MKD,North Macedonia,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32
MKD,North Macedonia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46
MKD,North Macedonia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30
MKD,North Macedonia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32
MKD,North Macedonia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
MKD,North Macedonia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28
MKD,North Macedonia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
MKD,North Macedonia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,39
MKD,North Macedonia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,41
MKD,North Macedonia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,40
MKD,North Macedonia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29
MKD,North Macedonia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20
MKD,North Macedonia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
MKD,North Macedonia,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,45
MKD,North Macedonia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,51
MKD,North Macedonia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30
MKD,North Macedonia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,49
MKD,North Macedonia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,37
MKD,North Macedonia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,45
MKD,North Macedonia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,43
MKD,North Macedonia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,45
MKD,North Macedonia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,47
MKD,North Macedonia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,47
MKD,North Macedonia,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,32
MKD,North Macedonia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,46
MKD,North Macedonia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,41
MKD,North Macedonia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,32
MKD,North Macedonia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
MKD,North Macedonia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,28
MKD,North Macedonia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
MKD,North Macedonia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,39
MKD,North Macedonia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,41
MKD,North Macedonia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,41
MLT,Malta,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
MLT,Malta,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,95
MLT,Malta,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
MLT,Malta,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
MLT,Malta,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
MLT,Malta,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
MLT,Malta,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
MLT,Malta,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,97
MLT,Malta,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
MLT,Malta,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
MLT,Malta,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29
MLT,Malta,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
MLT,Malta,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
MLT,Malta,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
MLT,Malta,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
MLT,Malta,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
MLT,Malta,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
MLT,Malta,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
MLT,Malta,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,96
MLT,Malta,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,76
MLT,Malta,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
MLT,Malta,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
MLT,Malta,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,95
MLT,Malta,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
MLT,Malta,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
MLT,Malta,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
MLT,Malta,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
MLT,Malta,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84
MLT,Malta,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
MLT,Malta,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,95
MLT,Malta,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
MLT,Malta,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,81
MLT,Malta,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,79
MLT,Malta,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
MMR,Myanmar,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
MMR,Myanmar,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8
MMR,Myanmar,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
MOZ,Mozambique,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
MOZ,Mozambique,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
MOZ,Mozambique,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32
MRT,Mauritania,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36
MRT,Mauritania,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28
MRT,Mauritania,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24
MRT,Mauritania,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,44
MRT,Mauritania,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,19
MUS,Mauritius,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
MUS,Mauritius,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
MUS,Mauritius,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
MUS,Mauritius,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
MUS,Mauritius,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
MUS,Mauritius,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
MUS,Mauritius,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,39
MUS,Mauritius,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
MUS,Mauritius,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
MUS,Mauritius,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
MUS,Mauritius,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
MUS,Mauritius,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
MUS,Mauritius,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21
MUS,Mauritius,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
MUS,Mauritius,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
MUS,Mauritius,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,58
MUS,Mauritius,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
MWI,Malawi,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
MWI,Malawi,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
MWI,Malawi,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,13
MWI,Malawi,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,13
MWI,Malawi,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
MWI,Malawi,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12
MWI,Malawi,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
MYS,Malaysia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,48
MYS,Malaysia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
MYS,Malaysia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
MYS,Malaysia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
MYS,Malaysia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
MYS,Malaysia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
MYS,Malaysia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
MYS,Malaysia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
MYS,Malaysia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
MYS,Malaysia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
MYS,Malaysia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
MYS,Malaysia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,14
MYS,Malaysia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,39
MYS,Malaysia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
MYS,Malaysia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,85
MYS,Malaysia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90
MYS,Malaysia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,84
MYS,Malaysia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
MYS,Malaysia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
MYS,Malaysia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,94
MYS,Malaysia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
MYS,Malaysia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
MYS,Malaysia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
MYS,Malaysia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,13
MYS,Malaysia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
MYS,Malaysia,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,48
MYS,Malaysia,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
MYS,Malaysia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
MYS,Malaysia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
MYS,Malaysia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
MYS,Malaysia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
MYS,Malaysia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
MYS,Malaysia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,94
MYS,Malaysia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,80
MYS,Malaysia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,80
MYS,Malaysia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
MYS,Malaysia,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
MYS,Malaysia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
MYS,Malaysia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,90
MYS,Malaysia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84
MYS,Malaysia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
MYS,Malaysia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,81
MYS,Malaysia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
MYS,Malaysia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
MYS,Malaysia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
MYS,Malaysia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
NIU,Niue,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
NIU,Niue,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,100
NIU,Niue,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,76
NIU,Niue,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,100
NLD,Netherlands (Kingdom of the),2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
NLD,Netherlands (Kingdom of the),2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
NLD,Netherlands (Kingdom of the),2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
NLD,Netherlands (Kingdom of the),2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
NLD,Netherlands (Kingdom of the),2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
NLD,Netherlands (Kingdom of the),2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
NLD,Netherlands (Kingdom of the),2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,60
NLD,Netherlands (Kingdom of the),2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,53
NLD,Netherlands (Kingdom of the),2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,52
NLD,Netherlands (Kingdom of the),2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
NLD,Netherlands (Kingdom of the),2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
NLD,Netherlands (Kingdom of the),2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
NLD,Netherlands (Kingdom of the),2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
NLD,Netherlands (Kingdom of the),2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
NLD,Netherlands (Kingdom of the),2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
NLD,Netherlands (Kingdom of the),2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
NLD,Netherlands (Kingdom of the),2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
NLD,Netherlands (Kingdom of the),2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
NLD,Netherlands (Kingdom of the),2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,61
NLD,Netherlands (Kingdom of the),2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,53
NLD,Netherlands (Kingdom of the),2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46
NLD,Netherlands (Kingdom of the),2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
NLD,Netherlands (Kingdom of the),2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,53
NLD,Netherlands (Kingdom of the),2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
NLD,Netherlands (Kingdom of the),2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
NLD,Netherlands (Kingdom of the),2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
NLD,Netherlands (Kingdom of the),2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,61
NLD,Netherlands (Kingdom of the),2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64
NLD,Netherlands (Kingdom of the),2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64
NLD,Netherlands (Kingdom of the),2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
NLD,Netherlands (Kingdom of the),2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
NLD,Netherlands (Kingdom of the),2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,61
NLD,Netherlands (Kingdom of the),2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,53
NLD,Netherlands (Kingdom of the),2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,52
NLD,Netherlands (Kingdom of the),2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,62
NLD,Netherlands (Kingdom of the),2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
NLD,Netherlands (Kingdom of the),2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
NLD,Netherlands (Kingdom of the),2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,55
NLD,Netherlands (Kingdom of the),2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,57
NLD,Netherlands (Kingdom of the),2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,57
NLD,Netherlands (Kingdom of the),2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
NLD,Netherlands (Kingdom of the),2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
NLD,Netherlands (Kingdom of the),2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,56
NLD,Netherlands (Kingdom of the),2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,51
NLD,Netherlands (Kingdom of the),2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,52
NLD,Netherlands (Kingdom of the),2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,52
NLD,Netherlands (Kingdom of the),2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,62
NLD,Netherlands (Kingdom of the),2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
NOR,Norway,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,72
NOR,Norway,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
NOR,Norway,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
NOR,Norway,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,84
NOR,Norway,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
NOR,Norway,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,88
NOR,Norway,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
NOR,Norway,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
NOR,Norway,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
NOR,Norway,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
NOR,Norway,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
NOR,Norway,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
NOR,Norway,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,96
NOR,Norway,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
NOR,Norway,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
NOR,Norway,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
NOR,Norway,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74
NOR,Norway,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
NOR,Norway,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
NOR,Norway,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
NOR,Norway,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,85
NOR,Norway,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,86
NOR,Norway,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
NOR,Norway,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90
NOR,Norway,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
NOR,Norway,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
NOR,Norway,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
NOR,Norway,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,80
NOR,Norway,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,77
NOR,Norway,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
NOR,Norway,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
NOR,Norway,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
NOR,Norway,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,91
NOR,Norway,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,92
NOR,Norway,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,93
NOR,Norway,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,92
NOR,Norway,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
NOR,Norway,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
NOR,Norway,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
NOR,Norway,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
NOR,Norway,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
NOR,Norway,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
NOR,Norway,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,87
NOR,Norway,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,88
NOR,Norway,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,92
NOR,Norway,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,92
NZL,New Zealand,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,49
NZL,New Zealand,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,52
NZL,New Zealand,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,53
NZL,New Zealand,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
NZL,New Zealand,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
NZL,New Zealand,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
NZL,New Zealand,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
NZL,New Zealand,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
NZL,New Zealand,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
NZL,New Zealand,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
NZL,New Zealand,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,69
NZL,New Zealand,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
NZL,New Zealand,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
NZL,New Zealand,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
NZL,New Zealand,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
NZL,New Zealand,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,53
NZL,New Zealand,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
NZL,New Zealand,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
NZL,New Zealand,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,59
NZL,New Zealand,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,60
NZL,New Zealand,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
NZL,New Zealand,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
NZL,New Zealand,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
NZL,New Zealand,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,62
NZL,New Zealand,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
NZL,New Zealand,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
NZL,New Zealand,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,50
NZL,New Zealand,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,53
NZL,New Zealand,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,55
NZL,New Zealand,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63
NZL,New Zealand,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63
NZL,New Zealand,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
NZL,New Zealand,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,70
NZL,New Zealand,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
NZL,New Zealand,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
NZL,New Zealand,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
NZL,New Zealand,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,46
NZL,New Zealand,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,45
NZL,New Zealand,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,55
NZL,New Zealand,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,58
NZL,New Zealand,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59
NZL,New Zealand,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,57
NZL,New Zealand,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
NZL,New Zealand,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
NZL,New Zealand,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
NZL,New Zealand,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
PAN,Panama,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
PAN,Panama,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
PAN,Panama,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,98
PAN,Panama,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
PAN,Panama,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
PAN,Panama,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
PAN,Panama,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
PAN,Panama,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
PAN,Panama,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
PAN,Panama,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
PAN,Panama,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
PAN,Panama,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
PAN,Panama,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
PAN,Panama,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
PAN,Panama,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
PAN,Panama,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
PAN,Panama,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,75
PAN,Panama,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
PAN,Panama,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
PAN,Panama,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
PAN,Panama,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
PAN,Panama,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
PAN,Panama,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
PAN,Panama,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
PAN,Panama,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
PAN,Panama,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
PAN,Panama,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PAN,Panama,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,90
PAN,Panama,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98
PAN,Panama,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84
PAN,Panama,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,85
PAN,Panama,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
PAN,Panama,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PAN,Panama,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
PAN,Panama,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
PAN,Panama,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,79
PAN,Panama,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
PAN,Panama,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
PAN,Panama,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
PAN,Panama,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,58
PAN,Panama,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,76
PAN,Panama,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
PER,Peru,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
PER,Peru,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
PER,Peru,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
PER,Peru,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,53
PER,Peru,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
PER,Peru,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
PER,Peru,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
PER,Peru,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
PER,Peru,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
PER,Peru,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46
PER,Peru,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36
PER,Peru,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67
PER,Peru,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
PER,Peru,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
PER,Peru,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
PER,Peru,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
PER,Peru,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
PER,Peru,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,49
PER,Peru,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,39
PER,Peru,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
PER,Peru,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
PER,Peru,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11
PER,Peru,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38
PER,Peru,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
PER,Peru,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,4
PER,Peru,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,19
PER,Peru,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46
PER,Peru,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
PER,Peru,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,65
PER,Peru,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
PER,Peru,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,68
PER,Peru,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3
PER,Peru,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,9
PER,Peru,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,33
PER,Peru,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
PER,Peru,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67
PER,Peru,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
PER,Peru,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,66
PHL,Philippines,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,27
PHL,Philippines,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33
PHL,Philippines,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,27
PHL,Philippines,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,14
PHL,Philippines,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23
PHL,Philippines,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23
PHL,Philippines,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4
PHL,Philippines,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
PHL,Philippines,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23
PHL,Philippines,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23
PHL,Philippines,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3
PHL,Philippines,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1
PHL,Philippines,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
PHL,Philippines,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5
PHL,Philippines,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
PHL,Philippines,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
PHL,Philippines,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,27
PHL,Philippines,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,33
PHL,Philippines,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23
PHL,Philippines,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23
PLW,Palau,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22
PLW,Palau,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34
PLW,Palau,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,40
PLW,Palau,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33
PLW,Palau,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35
PLW,Palau,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,54
PLW,Palau,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
PLW,Palau,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
PLW,Palau,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
PLW,Palau,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
PLW,Palau,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36
PLW,Palau,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,96
PLW,Palau,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9
PLW,Palau,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
PLW,Palau,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11
PLW,Palau,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23
PLW,Palau,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,26
PLW,Palau,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24
PLW,Palau,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31
PLW,Palau,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
PLW,Palau,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
PLW,Palau,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67
PLW,Palau,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21
PLW,Palau,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,40
PLW,Palau,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,49
PLW,Palau,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64
PLW,Palau,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,77
PLW,Palau,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,50
PLW,Palau,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
PLW,Palau,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PLW,Palau,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PLW,Palau,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PLW,Palau,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,19
PLW,Palau,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8
PLW,Palau,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,21
PLW,Palau,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34
PLW,Palau,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60
PLW,Palau,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
PLW,Palau,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
PLW,Palau,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
PRT,Portugal,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
PRT,Portugal,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
PRT,Portugal,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
PRT,Portugal,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
PRT,Portugal,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
PRT,Portugal,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
PRT,Portugal,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
PRT,Portugal,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
PRT,Portugal,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
PRT,Portugal,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
PRT,Portugal,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
PRT,Portugal,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
PRT,Portugal,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
PRT,Portugal,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,88
PRT,Portugal,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,89
PRT,Portugal,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90
PRT,Portugal,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
PRT,Portugal,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
PRT,Portugal,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,89
PRT,Portugal,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
PRT,Portugal,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,86
PRT,Portugal,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
PRT,Portugal,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
PRT,Portugal,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,91
PRT,Portugal,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90
PRT,Portugal,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,89
PRT,Portugal,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,96
PRT,Portugal,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98
PRT,Portugal,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PRT,Portugal,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PRT,Portugal,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PRT,Portugal,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98
PRT,Portugal,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,93
PRT,Portugal,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,96
PRT,Portugal,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,95
PRT,Portugal,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,97
PRT,Portugal,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
PRT,Portugal,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98
PRT,Portugal,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,96
PRT,Portugal,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,92
PRT,Portugal,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
PRT,Portugal,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,97
PRT,Portugal,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,96
PRT,Portugal,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,96
PRT,Portugal,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,93
PRT,Portugal,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
PRT,Portugal,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,90
PRT,Portugal,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,92
PRT,Portugal,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,95
PRT,Portugal,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,97
PRT,Portugal,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,96
PRT,Portugal,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
PRY,Paraguay,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
PRY,Paraguay,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
PRY,Paraguay,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
PRY,Paraguay,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
PRY,Paraguay,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
PRY,Paraguay,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
PRY,Paraguay,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,40
PRY,Paraguay,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
PRY,Paraguay,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
PRY,Paraguay,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
PRY,Paraguay,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,77
PRY,Paraguay,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
PRY,Paraguay,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
PRY,Paraguay,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
PRY,Paraguay,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
PRY,Paraguay,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
PRY,Paraguay,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,70
PRY,Paraguay,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24
PRY,Paraguay,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
PRY,Paraguay,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,18
PRY,Paraguay,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,95
PRY,Paraguay,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
PRY,Paraguay,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,79
PRY,Paraguay,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,77
PRY,Paraguay,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
PRY,Paraguay,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,77
PRY,Paraguay,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,83
PRY,Paraguay,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
PRY,Paraguay,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
PRY,Paraguay,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
PRY,Paraguay,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
PRY,Paraguay,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,72
RWA,Rwanda,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36
RWA,Rwanda,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
RWA,Rwanda,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
RWA,Rwanda,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
RWA,Rwanda,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
RWA,Rwanda,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,83
RWA,Rwanda,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
RWA,Rwanda,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
RWA,Rwanda,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,93
RWA,Rwanda,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
RWA,Rwanda,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
RWA,Rwanda,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
RWA,Rwanda,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
RWA,Rwanda,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
RWA,Rwanda,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
RWA,Rwanda,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
RWA,Rwanda,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
RWA,Rwanda,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
RWA,Rwanda,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
RWA,Rwanda,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,81
RWA,Rwanda,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90
RWA,Rwanda,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66
RWA,Rwanda,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
RWA,Rwanda,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,75
RWA,Rwanda,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,18
RWA,Rwanda,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30
RWA,Rwanda,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,39
RWA,Rwanda,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,48
RWA,Rwanda,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60
RWA,Rwanda,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
RWA,Rwanda,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,79
RWA,Rwanda,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
RWA,Rwanda,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
RWA,Rwanda,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
RWA,Rwanda,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,93
RWA,Rwanda,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,17
RWA,Rwanda,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29
RWA,Rwanda,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,37
RWA,Rwanda,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,44
RWA,Rwanda,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,54
RWA,Rwanda,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63
RWA,Rwanda,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73
RWA,Rwanda,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
RWA,Rwanda,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
RWA,Rwanda,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,82
RWA,Rwanda,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,90
SAU,Saudi Arabia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
SEN,Senegal,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
SEN,Senegal,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
SEN,Senegal,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
SEN,Senegal,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
SEN,Senegal,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,25
SEN,Senegal,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32
SEN,Senegal,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
SEN,Senegal,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,25
SGP,Singapore,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
SGP,Singapore,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
SGP,Singapore,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
SGP,Singapore,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
SGP,Singapore,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
SGP,Singapore,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
SGP,Singapore,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,39
SGP,Singapore,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,75
SGP,Singapore,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
SGP,Singapore,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
SGP,Singapore,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
SGP,Singapore,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
SGP,Singapore,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
SGP,Singapore,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
SGP,Singapore,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
SGP,Singapore,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
SGP,Singapore,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
SGP,Singapore,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28
SGP,Singapore,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,58
SGP,Singapore,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
SGP,Singapore,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,88
SGP,Singapore,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71
SGP,Singapore,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,0
SGP,Singapore,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1
SGP,Singapore,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1
SGP,Singapore,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1
SGP,Singapore,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1
SGP,Singapore,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1
SGP,Singapore,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1
SGP,Singapore,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,39
SGP,Singapore,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
SGP,Singapore,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
SGP,Singapore,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,0
SGP,Singapore,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1
SGP,Singapore,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1
SGP,Singapore,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1
SGP,Singapore,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1
SGP,Singapore,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1
SGP,Singapore,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1
SGP,Singapore,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,28
SGP,Singapore,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,58
SGP,Singapore,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
SLB,Solomon Islands,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
SLB,Solomon Islands,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
SLB,Solomon Islands,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11
SLB,Solomon Islands,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9
SLB,Solomon Islands,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,19
SLB,Solomon Islands,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
SLB,Solomon Islands,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
SLB,Solomon Islands,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
SLB,Solomon Islands,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
SLB,Solomon Islands,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,19
SLB,Solomon Islands,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,19
SLB,Solomon Islands,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,19
SLE,Sierra Leone,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
SLV,El Salvador,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28
SLV,El Salvador,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64
SLV,El Salvador,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
SLV,El Salvador,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38
SLV,El Salvador,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
SMR,San Marino,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19
SMR,San Marino,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,16
SMR,San Marino,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19
SMR,San Marino,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,10
SMR,San Marino,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,20
SMR,San Marino,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,43
SMR,San Marino,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63
SMR,San Marino,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,49
SMR,San Marino,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35
SMR,San Marino,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
SMR,San Marino,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
SMR,San Marino,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22
SMR,San Marino,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
SMR,San Marino,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,19
SMR,San Marino,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
SMR,San Marino,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,13
SMR,San Marino,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,16
SMR,San Marino,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46
SMR,San Marino,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,51
SMR,San Marino,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
SMR,San Marino,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22
SMR,San Marino,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,48
SMR,San Marino,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,17
SMR,San Marino,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,13
SMR,San Marino,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29
SMR,San Marino,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,41
SMR,San Marino,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,28
SMR,San Marino,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
SMR,San Marino,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
SMR,San Marino,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,14
SMR,San Marino,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7
SMR,San Marino,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,32
SMR,San Marino,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,37
SMR,San Marino,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23
SMR,San Marino,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,61
SMR,San Marino,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
SRB,Serbia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2
SRB,Serbia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
SUR,Suriname,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,57
SUR,Suriname,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62
SUR,Suriname,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34
SUR,Suriname,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
SUR,Suriname,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
SUR,Suriname,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,49
SUR,Suriname,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,16
SUR,Suriname,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3
SUR,Suriname,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8
SUR,Suriname,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
SUR,Suriname,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,62
SUR,Suriname,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34
SUR,Suriname,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
SUR,Suriname,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
SUR,Suriname,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
SUR,Suriname,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
SUR,Suriname,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
SUR,Suriname,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2
SUR,Suriname,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,57
SUR,Suriname,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,57
SUR,Suriname,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,57
SUR,Suriname,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,57
SUR,Suriname,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,57
SUR,Suriname,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,62
SUR,Suriname,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,34
SUR,Suriname,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,36
SUR,Suriname,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,36
SUR,Suriname,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,36
SUR,Suriname,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,36
SUR,Suriname,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,36
SUR,Suriname,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,62
SUR,Suriname,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34
SVK,Slovakia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30
SVK,Slovakia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14
SVN,Slovenia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,44
SVN,Slovenia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46
SVN,Slovenia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,50
SVN,Slovenia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38
SVN,Slovenia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,43
SVN,Slovenia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,40
SVN,Slovenia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,41
SVN,Slovenia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,43
SVN,Slovenia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
SVN,Slovenia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,52
SVN,Slovenia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,54
SVN,Slovenia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38
SVN,Slovenia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,45
SVN,Slovenia,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
SVN,Slovenia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46
SVN,Slovenia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
SVN,Slovenia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38
SVN,Slovenia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
SVN,Slovenia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,40
SVN,Slovenia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,41
SVN,Slovenia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
SVN,Slovenia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
SVN,Slovenia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,52
SVN,Slovenia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,54
SVN,Slovenia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38
SVN,Slovenia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
SVN,Slovenia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,44
SVN,Slovenia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,45
SVN,Slovenia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,49
SVN,Slovenia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,38
SVN,Slovenia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,43
SVN,Slovenia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,39
SVN,Slovenia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,40
SVN,Slovenia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,42
SVN,Slovenia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,44
SVN,Slovenia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,44
SVN,Slovenia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,45
SVN,Slovenia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,49
SVN,Slovenia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,38
SVN,Slovenia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,43
SVN,Slovenia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,39
SVN,Slovenia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,40
SVN,Slovenia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,42
SVN,Slovenia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,44
SWE,Sweden,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
SWE,Sweden,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
SWE,Sweden,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
SWE,Sweden,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,82
SWE,Sweden,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,86
SWE,Sweden,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
SWE,Sweden,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
SWE,Sweden,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
SWE,Sweden,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73
SWE,Sweden,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72
SWE,Sweden,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,75
SWE,Sweden,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
SWE,Sweden,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,82
SWE,Sweden,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
SWE,Sweden,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,83
SWE,Sweden,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
SWE,Sweden,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,83
SWE,Sweden,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
SWE,Sweden,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
SWE,Sweden,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,81
SWE,Sweden,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
SWE,Sweden,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
SWE,Sweden,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89
SWE,Sweden,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78
SWE,Sweden,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,76
SWE,Sweden,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75
SWE,Sweden,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
SWE,Sweden,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84
SWE,Sweden,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,85
SYC,Seychelles,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
SYC,Seychelles,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90
SYC,Seychelles,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94
SYC,Seychelles,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
SYC,Seychelles,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,92
SYC,Seychelles,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,91
SYC,Seychelles,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,97
SYC,Seychelles,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
SYC,Seychelles,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,96
SYC,Seychelles,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
SYC,Seychelles,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,88
SYC,Seychelles,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,93
SYC,Seychelles,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,78
SYC,Seychelles,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,93
SYC,Seychelles,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64
SYC,Seychelles,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23
SYC,Seychelles,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38
SYC,Seychelles,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,84
SYC,Seychelles,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,80
SYC,Seychelles,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,92
SYC,Seychelles,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,96
SYC,Seychelles,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,86
SYC,Seychelles,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,93
SYC,Seychelles,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
SYC,Seychelles,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,89
SYC,Seychelles,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,93
SYC,Seychelles,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,80
SYC,Seychelles,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,94
THA,Thailand,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
THA,Thailand,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
THA,Thailand,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
THA,Thailand,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
THA,Thailand,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
THA,Thailand,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
THA,Thailand,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,70
THA,Thailand,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30
THA,Thailand,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
THA,Thailand,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
THA,Thailand,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
THA,Thailand,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
THA,Thailand,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73
THA,Thailand,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
THA,Thailand,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71
THA,Thailand,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30
TKM,Turkmenistan,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,97
TKM,Turkmenistan,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,95
TKM,Turkmenistan,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,95
TKM,Turkmenistan,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
TKM,Turkmenistan,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,97
TKM,Turkmenistan,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,95
TON,Tonga,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,20
TON,Tonga,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20
TON,Tonga,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,22
TON,Tonga,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,22
TTO,Trinidad and Tobago,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,18
TTO,Trinidad and Tobago,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,13
TTO,Trinidad and Tobago,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
TTO,Trinidad and Tobago,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,20
TTO,Trinidad and Tobago,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30
TTO,Trinidad and Tobago,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,17
TTO,Trinidad and Tobago,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,18
TTO,Trinidad and Tobago,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22
TTO,Trinidad and Tobago,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
TTO,Trinidad and Tobago,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6
TTO,Trinidad and Tobago,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6
TTO,Trinidad and Tobago,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12
TTO,Trinidad and Tobago,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,13
TTO,Trinidad and Tobago,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
TTO,Trinidad and Tobago,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
TTO,Trinidad and Tobago,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8
TTO,Trinidad and Tobago,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,13
TTO,Trinidad and Tobago,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,50
TTO,Trinidad and Tobago,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,20
TTO,Trinidad and Tobago,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,28
TTO,Trinidad and Tobago,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6
TTO,Trinidad and Tobago,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6
TTO,Trinidad and Tobago,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,12
TTO,Trinidad and Tobago,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,13
TUV,Tuvalu,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
TUV,Tuvalu,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
TUV,Tuvalu,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27
TUV,Tuvalu,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,80
TZA,United Republic of Tanzania,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,49
TZA,United Republic of Tanzania,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
TZA,United Republic of Tanzania,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,78
TZA,United Republic of Tanzania,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
TZA,United Republic of Tanzania,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,79
TZA,United Republic of Tanzania,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,18
TZA,United Republic of Tanzania,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46
TZA,United Republic of Tanzania,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
TZA,United Republic of Tanzania,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,55
TZA,United Republic of Tanzania,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,60
TZA,United Republic of Tanzania,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46
TZA,United Republic of Tanzania,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
TZA,United Republic of Tanzania,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
TZA,United Republic of Tanzania,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,70
TZA,United Republic of Tanzania,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,16
TZA,United Republic of Tanzania,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,44
TZA,United Republic of Tanzania,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,54
TZA,United Republic of Tanzania,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,55
UGA,Uganda,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
UGA,Uganda,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
UGA,Uganda,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
UGA,Uganda,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
UGA,Uganda,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
UGA,Uganda,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,77
UGA,Uganda,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
UGA,Uganda,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30
UGA,Uganda,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,57
UGA,Uganda,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,75
UGA,Uganda,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65
UGA,Uganda,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31
UGA,Uganda,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
UGA,Uganda,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
UGA,Uganda,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
UGA,Uganda,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
UGA,Uganda,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30
UGA,Uganda,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,57
URY,Uruguay,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35
URY,Uruguay,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,61
URY,Uruguay,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
URY,Uruguay,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74
URY,Uruguay,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76
URY,Uruguay,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38
URY,Uruguay,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,54
URY,Uruguay,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,61
URY,Uruguay,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,26
URY,Uruguay,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,45
URY,Uruguay,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
URY,Uruguay,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
URY,Uruguay,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,37
URY,Uruguay,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24
URY,Uruguay,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17
URY,Uruguay,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22
URY,Uruguay,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,40
URY,Uruguay,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,62
URY,Uruguay,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,66
URY,Uruguay,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
URY,Uruguay,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,70
URY,Uruguay,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,33
URY,Uruguay,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,49
URY,Uruguay,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,49
URY,Uruguay,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,46
URY,Uruguay,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,48
USA,United States,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,39
USA,United States,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,42
USA,United States,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
USA,United States,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
USA,United States,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,51
USA,United States,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,56
USA,United States,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55
USA,United States,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
USA,United States,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,61
USA,United States,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68
USA,United States,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71
USA,United States,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
USA,United States,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
USA,United States,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23
USA,United States,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23
USA,United States,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20
USA,United States,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,26
USA,United States,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,26
USA,United States,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30
USA,United States,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36
USA,United States,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,44
USA,United States,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,39
USA,United States,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,49
USA,United States,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,48
USA,United States,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
USA,United States,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,50
USA,United States,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,51
USA,United States,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,56
USA,United States,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,54
USA,United States,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59
USA,United States,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,61
USA,United States,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63
USA,United States,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,68
USA,United States,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67
USA,United States,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71
USA,United States,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,76
USA,United States,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78
USA,United States,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
USA,United States,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
USA,United States,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,32
USA,United States,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,38
USA,United States,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,35
USA,United States,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,39
USA,United States,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,41
USA,United States,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,44
USA,United States,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,52
USA,United States,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,53
USA,United States,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,55
USA,United States,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,62
USA,United States,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
USA,United States,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
USA,United States,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,69
UZB,Uzbekistan,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,96
UZB,Uzbekistan,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
UZB,Uzbekistan,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
UZB,Uzbekistan,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
UZB,Uzbekistan,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,96
UZB,Uzbekistan,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,88
UZB,Uzbekistan,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99
UZB,Uzbekistan,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
VCT,Saint Vincent and the Grenadines,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,16
VCT,Saint Vincent and the Grenadines,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4
VCT,Saint Vincent and the Grenadines,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11
VCT,Saint Vincent and the Grenadines,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3
VCT,Saint Vincent and the Grenadines,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4
VCT,Saint Vincent and the Grenadines,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11
VCT,Saint Vincent and the Grenadines,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,13
VCT,Saint Vincent and the Grenadines,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,17
VCT,Saint Vincent and the Grenadines,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,4
VCT,Saint Vincent and the Grenadines,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,18
WSM,Samoa,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
WSM,Samoa,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,87
ZAF,South Africa,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,87
ZAF,South Africa,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,85
ZAF,South Africa,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,81
ZAF,South Africa,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
ZAF,South Africa,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
ZAF,South Africa,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70
ZAF,South Africa,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3
ZAF,South Africa,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38
ZAF,South Africa,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47
ZAF,South Africa,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
ZAF,South Africa,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
ZAF,South Africa,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63
ZAF,South Africa,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56
ZAF,South Africa,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
ZAF,South Africa,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,43
ZAF,South Africa,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
ZAF,South Africa,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35
ZAF,South Africa,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47
ZAF,South Africa,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,11
ZAF,South Africa,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,32
ZAF,South Africa,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,79
ZAF,South Africa,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,82
ZAF,South Africa,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,72
ZAF,South Africa,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,10
ZAF,South Africa,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30
ZAF,South Africa,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64
ZAF,South Africa,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74
ZAF,South Africa,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,56
ZMB,Zambia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99
ZMB,Zambia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73
ZMB,Zambia,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,44
ZMB,Zambia,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66
ZMB,Zambia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68
ZMB,Zambia,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33
ZMB,Zambia,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38
ZMB,Zambia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99
ZMB,Zambia,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75
ZMB,Zambia,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,44
ZMB,Zambia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68
ZMB,Zambia,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,33
ZMB,Zambia,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,38
ZWE,Zimbabwe,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,80
ZWE,Zimbabwe,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,89
ZWE,Zimbabwe,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,0
ZWE,Zimbabwe,2021,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65
ZWE,Zimbabwe,2022,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6
ZWE,Zimbabwe,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65
ZWE,Zimbabwe,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,0
ZWE,Zimbabwe,2021,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,40
ZWE,Zimbabwe,2022,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7
ZWE,Zimbabwe,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74
ZWE,Zimbabwe,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,87
ZWE,Zimbabwe,2021,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,88
ZWE,Zimbabwe,2022,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,80
ZWE,Zimbabwe,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,65
ZWE,Zimbabwe,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,65
ZWE,Zimbabwe,2021,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,65
ZWE,Zimbabwe,2022,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,65
